Eliana Blini Marengo

Graduated in Pharmacy at Universidade do Oeste Paulista (2000), master (2003) and PhD (2008) in Molecular Biology (Biochemistry) at Federal University of Sao Paulo. Coordinator of Biotechnological Quality Control at Butantan Institute (from 2014 to June, 2020) and Head of QC in Dechra PLC (2021-2022). In addition, worked as a pharmacist in charge for clinical studies of new vaccines (Tdap and Dengue 1,2,3,4), and also coordinated the routine activities in the Strategic Diagnostic Laboratory during the COVID-19 epidemic both at the Butantan Institute. Member of the CEUA, CIBio and Scientific Integrity committees of the Hospital Israelita Albert Einstein. She is currently responsible for Quality at the Dayan-Daycoval Advanced Therapies Research Center (NPTA) at Hospital Israelita Albert Einstein. (Source: Lattes Curriculum)